Production of carrier-free scandium radioisotopes from a neutron-irradiated potassium titanium oxalate target

Summary Extraction of scandium and calcium radioactivities with 1% HDEHP in benzene from nitric acid solution was investigated. The effect of potassium titanium oxalate concentration on the extraction from 1.5M nitric acid was studied. From the data obtained, two procedures based on batch solvent extraction and extraction chromatography were developed for separation and production of radioscandium from a neutron-irradiated potassium titanium oxalate target. The radiochemical purity of the separated scandium radioactivities was more than 98%.

---

Zusammenfassung Die Extraktion der Aktivitäten des Scandiums und Calciums aus salpetersaurer Lösung mit 1% Diäthylhexylphosphorsäure in Benzol wurde untersucht. Der Einfluß der Kalium-Titanoxalat-Konzentration auf die Extraktion aus 1,5-m Salpetersäure wurde geprüft. Auf Grund der Ergebnisse wurden zwei Verfahren zur Trennung und Gewinnung von Radio-Scandium aus einem neutronenbestrahlten Kalium-Titanoxalat-Target ausgearbeitet, die auf einmaliger Extraktion mit dem Lösungsmittel bzw. auf Extraktionschromatographie beruhen. Die radiochemische Reinheit der Sc-Aktivitäten war besser als 98%.

     

Die Veresterungsgeschwindigkeiten der Monoaminobenzoesäuren und der 1- und 2-Pyridinkarbonsäuren in Glykol und Glyzerin

Zusammenfassung Es werden die Veresterungsgeschwindigkeiten der Monoaminobenzoesäuren und der 1- und 2-Pyridinkarbonsäuren bei 25° mit Chlorwasserstoff als Katalysator sowohl in wasserfreiem als auch in wasserhaltigem Glykol und in wasserfreiem Glyzerin gemessen, die derm- und derp-Aminobenzoesäure und der 2-Pyridinkarbonsäure (Nikotinsäure) auch in wasserhaltigem Glyzerin. Die Abhängigkeit der monomolekularen Geschwindigkeitskonstanten vom Wassergehalt (w) des Mediums und dem Überschuß der Konzentration der Salzsäure über die der organischen Säure, bzw. ihres Esters (C) wird für die drei zuletzt genannten Säuren durch Formeln dargestellt. Diese Geschwindigkeitskonstanten nehmen durchwegs sowohl in wasserfreiem als auch in wasserhaltigem Glykol und Glyzerin nicht nur rascher als die Konzentration der gesamten Salzsäure, sondern auch als die des obigen Überschusses, d. h. der freien Salzsäure, zu.FürC=1/3 sind beiw=0.03 die Geschwindigkeitskonstanten derm- und derp-Aminobenzoesäure und der Nikotinsäure in Äthylalkohol um 20–30 %, die der Anthranilsäure um 70%, die der Pikolinsäure um 130% größer als in Glykol, beiw=0.7 dagegen die der drei ersteren Säuren um 35–50% kleiner.In Glykol sind die Konstanten bei der Anthranilsäure und den Pyridinkarbonsäuren kleiner als in Glyzerin, bei den übrigen wie bei den früher untersuchten Säuren aber größer.Die sterische Wirkung der Aminogruppe in Orthostellung ist in Glykol größer, in Glyzerin kleiner als in Äthylalkohol.Unter gleichen Bedingungen Bind die Konstanten der Veresterungsgeschwindigkeit der Nikotinsäure in Glykol und Glyzerin etwa viermal, in Äthylalkohol nur etwa zweimal größer als die der Pikolinsäure.     

Preparation of234Th(UX1) by extraction of238U. determination of thorium with arsenazo-III

Summary Radiochemical procedures have been worked out to prepare²³⁴Th(UX₁) with and without carrier from uranium using N-oxide of 4-(5-nonyl)pyridine in sulphuric acid media. This reagent has also been employed in the development of a combined solvent extraction-ion exchange-spectrophotometric method for the determination of thorium in various samples.

---

Zusammenfassung Radiochemische Methoden zur Herstellung von²³⁴Th(UX₁) aus Uran mit und ohne Träger und unter Verwendung von 4-(5-Nonyl)pyridin-N-oxid in schwefelsaurer Lösung wurden ausgearbeitet. Dieses Reagens wurde auch für die Ausarbeitung einer Thoriumbestimmung in verschiedenartigen Proben auf der Grundlage von Extraktion, Ionenaustausch und Spektro-photometrie verwendet.

     

Positive and negative ion mass spectra of oxygen,sulphur and selenium 2,1,3-benzodiazoles

The 70 eV positive and negative ion mass spectra of the oxygen, sulphur and selenium 2,1,3-benzodiazoles have been studied. The influence of hetero atom on the fragmentation modes of the benzodiazole molecular ions has been discussed.     

Carnosic Acid Encapsulated in Albumin Nanoparticles Induces Apoptosis in Breast and Colorectal Cancer Cells

Carnosic acid (CA) is a natural phenolic compound with several biomedical actions. This work was performed to study the use of CA-loaded polymeric nanoparticles to improve the antitumor activity of breast cancer cells (MCF-7) and colon cancer cells (Caco-2). CA was encapsulated in bovine serum albumin (BSA), chitosan (CH), and cellulose (CL) nanoparticles. The CA-loaded BSA nanoparticles (CA-BSA-NPs) revealed the most promising formula as it showed good loading capacity and the best release rate profile as the drug reached 80% after 10 h. The physicochemical characterization of the CA-BSA-NPs and empty carrier (BSA-NPs) was performed by the particle size distribution analysis, transmission electron microscopy (TEM), and zeta potential. The antitumor activity of the CA-BSA-NPs was evaluated by measuring cell viability, apoptosis rate, and gene expression of GCLC, COX-2, and BCL-2 in MCF-7 and Caco-2. The cytotoxicity assay (MTT) showed elevated antitumor activity of CA-BSA-NPs against MCF-7 and Caco-2 compared to free CA and BSA-NPs. Moreover, apoptosis test data showed an arrest of the Caco-2 cells at G₂/M (10.84%) and the MCF-7 cells at G2/M (4.73%) in the CA-BSA-NPs treatment. RT-PCR-based gene expression analysis showed an upregulation of the GCLC gene and downregulation of the BCL-2 and COX-2 genes in cells treated with CA-BSA-NPs compared to untreated cells. In conclusion, CA-BSA-NPs has been introduced as a promising formula for treating breast and colorectal cancer.     

The Intestinal and Biliary Metabolites of Ibuprofen in the Rat with Experimental Hyperglycemia

Hyperglycemia is reported to be associated with oxidative stress. It can result in changes in the activities of drug-metabolizing enzymes and membrane-integrated transporters, which can modify the fate of drugs and other xenobiotics; furthermore, it can result in the formation of non-enzyme catalyzed oxidative metabolites. The present work aimed to investigate how experimental hyperglycemia affects the intestinal and biliary appearance of the oxidative and Phase II metabolites of ibuprofen in rats. In vivo studies were performed by luminal perfusion of 250 μM racemic ibuprofen solution in control and streptozotocin-treated (hyperglycemic) rats. Analysis of the collected intestinal perfusate and bile samples was performed by HPLC-UV and HPLC-MS. No oxidative metabolites could be detected in the perfusate samples. The biliary appearance of ibuprofen, 2-hydroxyibuprofen, ibuprofen glucuronide, hydroxylated ibuprofen glucuronide, and ibuprofen taurate was depressed in the hyperglycemic animals. However, no specific non-enzymatic (hydroxyl radical initiated) hydroxylation product could be detected. Instead, the depression of biliary excretion of ibuprofen and ibuprofen metabolites turned out to be the indicative marker of hyperglycemia. The observed changes impact the pharmacokinetics of drugs administered in hyperglycemic individuals.     

Simultaneous Estimation of Escitalopram and Clonazepam in Tablet Dosage Forms Using HPLC-DAD Method and Optimization of Chromatographic Conditions by Box-Behnken Design

The study aimed to develop a new reverse-phase high-performance liquid chromatography (RP-HPLC) method with diode array detection (DAD) detection for simultaneous estimation of escitalopram (EST) and clonazepam (CZP) in tablet dosage forms with a quality by design (QbD) approach. The chromatographic conditions were optimized by Box-Behnken design (BBD) and developed method was validated for the linearity, system suitability, accuracy, precision, robustness, sensitivity, and solution stability according to International Council for Harmonization (ICH) guidelines. EST and CZP standard drugs peaks were separated at retention times of 2.668 and 5.046 min by C-18 column with dimension of 4.6 × 100 mm length and particle size packing 2.5 µm. The mobile phase was methanol: 0.1% orthophosphoric acid (OPA) (25:75, v/v), with a flow rate of 0.7 mL/min at temperature of 26 °C. The sample volume injected was 20 µL and peaks were detected at 239 nm. Using the standard calibration curve, the % assay of marketed tablet was founded 98.89 and 98.76 for EST and CZP, respectively. The proposed RP-HPLC method was able to detect EST and CZP in the presence of their degradation products, indicating the stability-indicating property of the developed RP-HPLC method. The validation parameter’s results in terms of linearity, system suitability, accuracy, precision, robustness, sensitivity, and solution stability were in an acceptable range as per the ICH guidelines. The newly developed RP-HPLC method with QbD application is simple, accurate, time-saving, and economic.     

Sarcorucinine-D Inhibits Cholinesterases and Calcium Channels: Molecular Dynamics Simulation and In Vitro Mechanistic Investigations

Acetylcholinesterase (AChE) inhibitors and calcium channel blockers are considered effective therapies for Alzheimer’s disease. AChE plays an essential role in the nervous system by catalyzing the hydrolysis of the neurotransmitter acetylcholine. In this study, the inhibition of the enzyme AChE by Sarcorucinine-D, a pregnane type steroidal alkaloid, was investigated with experimental enzyme kinetics and molecular dynamics (MD) simulation techniques. Kinetics studies showed that Sarcorucinine-D inhibits two cholinesterases—AChE and butyrylcholinesterase (BChE)—noncompetitively, with K_i values of 103.3 and 4.66 µM, respectively. In silico ligand-protein docking and MD simulation studies conducted on AChE predicted that Sarcorucinine-D interacted via hydrophobic interactions and hydrogen bonds with the residues of the active-site gorge of AChE. Sarcorucinine-D was able to relax contractility concentration-dependently in the intestinal smooth muscles of jejunum obtained from rabbits. Not only was the spontaneous spasmogenicity inhibited, but it also suppressed K⁺-mediated spasmogenicity, indicating an effect via the inhibition of voltage-dependent Ca²⁺ channels. Sarcorucinine-D could be considered a potential lead molecule based on its properties as a noncompetitive AChE inhibitor and a Ca²⁺ channel blocker.     

Solubility Optimization of Loxoprofen as a Nonsteroidal Anti-Inflammatory Drug: Statistical Modeling and Optimization

Industrial-based application of supercritical CO₂ (SCCO₂) has emerged as a promising technology in numerous scientific fields due to offering brilliant advantages, such as simplicity of application, eco-friendliness, and high performance. Loxoprofen sodium (chemical formula C₁₅H₁₈O₃) is known as an efficient nonsteroidal anti-inflammatory drug (NSAID), which has been long propounded as an effective alleviator for various painful disorders like musculoskeletal conditions. Although experimental research plays an important role in obtaining drug solubility in SCCO₂, the emergence of operational disadvantages such as high cost and long-time process duration has motivated the researchers to develop mathematical models based on artificial intelligence (AI) to predict this important parameter. Three distinct models have been used on the data in this work, all of which were based on decision trees: K-nearest neighbors (KNN), NU support vector machine (NU-SVR), and Gaussian process regression (GPR). The data set has two input characteristics, P (pressure) and T (temperature), and a single output, Y = solubility. After implementing and fine-tuning to the hyperparameters of these ensemble models, their performance has been evaluated using a variety of measures. The R-squared scores of all three models are greater than 0.9, however, the RMSE error rates are 1.879 × 10⁻⁴, 7.814 × 10⁻⁵, and 1.664 × 10⁻⁴ for the KNN, NU-SVR, and GPR models, respectively. MAE metrics of 1.116 × 10⁻⁴, 6.197 × 10⁻⁵, and 8.777 × 10⁻⁵errors were also discovered for the KNN, NU-SVR, and GPR models, respectively. A study was also carried out to determine the best quantity of solubility, which can be referred to as the (x₁ = 40.0, x₂ = 338.0, Y = 1.27 × 10⁻³) vector.     

Development,In-Vitro Characterization and Preclinical Evaluation of Esomeprazole-Encapsulated Proniosomal Formulation for the Enhancement of Anti-Ulcer Activity

Objective: The present study aimed to develop and optimize esomeprazole loaded proniosomes (EZL-PNs) to improve bioavailability and therapeutic efficacy. Method: EZL-PNs formulation was developed by slurry method and optimized by 33 box-Bhekhen statistical design software. Span 60 (surfactant), cholesterol, EZL concentration were taken as independent variables and their effects were evaluated on vesicle size (nm), entrapment efficiency (%, EE) and drug release (%, DR). Furthermore, optimized EZL-PNs (EZL-PNs-opt) formulation was evaluated for ex vivo permeation, pharmacokinetic and ulcer protection activity. Result: The EZL-PNs-opt formulation showed 616 ± 13.21 nm of vesicle size, and 81.21 ± 2.35% of EE. EZL-PNs-opt exhibited negative zeta potential and spherical confirmed scanning electron microscopy. EZL-PNs-opt showed sustained release of EZL (95.07 ± 2.10% in 12 h) than pure EZL dispersion. The ex-vivo gut permeation result exhibited a significantly (p < 0.05) enhanced flux than pure EZL. The in vivo results revealed 4.02-fold enhancement in bioavailability and 61.65% protection in ulcer than pure EZL dispersion (43.82%). Conclusion: Our findings revealed that EZL-PNs formulation could be an alternative delivery system of EZL to enhance oral bioavailability and antiulcer activity.